Description
Documents Gower's ten years (1982-1992) at Genentech in Commerce, Industry, and Labor development and pharmaceutical sales and marketing, ultimately as senior vice president. Describes his part in the launch of human growth hormone and in decisions regarding tissue plasminogen activator (t-PA), the company's "[blood] clot buster"; role in the acquisition of the company by Hoffmann-La Roche.